ProShare Advisors’s Usana Health Sciences USNA Stock Holding History

ProShare Advisors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,657	Closed	-$211K	–	2131
2022 Q1	$211K	Sell	2,657 -331	-11%	-$29.8K	﹤0.01%	1857
2021 Q4	$303K	Buy	+2,988	New	+$298K	﹤0.01%	1781
2021 Q3	–	Sell	-3,609	Closed	-$370K	–	2272
2021 Q2	$370K	Buy	3,609 +167	+5%	+$16.8K	﹤0.01%	1749
2021 Q1	$336K	Buy	3,442 +648	+23%	+$59K	﹤0.01%	1730
2020 Q4	$215K	Buy	+2,794	New	+$216K	﹤0.01%	1814
2014 Q3	–	Sell	-6,280	Closed	-$245K	–	2359
2014 Q2	$245K	Sell	6,280 -5,878	-48%	-$218K	﹤0.01%	2048
2014 Q1	$458K	Buy	+12,158	New	+$425K	0.01%	1937
2013 Q4	–	Sell	-7,580	Closed	-$329K	–	1862
2013 Q3	$329K	Buy	7,580 +534	+8%	+$21.4K	0.01%	1823
2013 Q2	$255K	Buy	+7,046	New	+$214K	0.01%	1847

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

ProShare Advisors's USNA Position: Q2 2022 in Review

ProShare Advisors sold out of Usana Health Sciences (USNA) in Q2 2022, closing a stake of 2,657 shares — an estimated $211K sold.

ProShare Advisors first reported a position in USNA in Q2 2013 and held it in 9 quarters. The position peaked at $458K in Q1 2014. 182 funds tracked by Wall St. Rank hold USNA as of Q2 2022.

ProShare Advisors reported no remaining Usana Health Sciences position as of Q2 2022 after selling out during the quarter.
ProShare Advisors sold 2,657 Usana Health Sciences shares in Q2 2022, an estimated $211K.
ProShare Advisors first reported a position in Usana Health Sciences in Q2 2013 and held it in 9 quarters.
ProShare Advisors's Usana Health Sciences position peaked at $458K in Q1 2014.
182 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.